Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/23116
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Antineoplastic Agents/administration & dosage/adverse effects/*therapeutic use,Brain Neoplasms/*drug therapy,Carbamates/administration & dosage/adverse effects/*therapeutic use,Disease-Free Survival,Female,Glioma/*drug therapy,Humans,Infusions, Intravenous,Male,Maximum Tolerated Dose,Middle Aged,Neoplasm Recurrence, Local/*drug therapy,Pyrazines/administration & dosage/adverse effects/*therapeutic use,Pyridines/administration & dosage/adverse effects/*therapeutic use,Survival Rate,Thrombocytopenia/chemically induced,Treatment Outcome
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/23116
ISSN: 0735-7907
Link: http://www.ncbi.nlm.nih.gov/pubmed/12449727
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons